Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

The enzyme 17β-HSD type 2 mainly performs oxidation in human sebaceous glands, which may help protect against acne.

Finasteride improves immune response and reduces organ damage after trauma hemorrhage in mice.

High levels of prolactin in the blood can be linked to widespread hair loss.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Melatonin may help treat PCOS symptoms in rats.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Reversing female hair loss.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.